BridgeMD
New treatment option for Depression in Old Age
Official title Engage for Late-Life Depression and Comorbid Executive Dysfunction
ClinicalTrials.gov ID: NCT05356611
What this study is testing
- What it's testing
- Although there are an increasing number of mental health treatment adaptations for older adults, there are still a number of factors to consider when making these adaptations. Cognitive decline is one such factor that places significant burden on older adults and can interfere with traditional mental health therapies.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- Age 60 or older
- Ability to read, write, and speak English
- Located in Las Vegas or surrounding area
- Ability to travel to UNLV campus by self or possible caregiver for regular study visits
- Clinically significant symptoms of depression as evidenced by: 1) Scores \> 5 on the Geriatric Depression Scale-Short Form (GDS-SF)
You likely can't join if
- Active suicidal ideation
- History of suicide attempt(s)
- Current symptoms of: 1) Psychosis; 2) Active substance use disorder
- Reported history of: 1) Bipolar disorder ("manic depression"); 2) Intellectual disability
- Currently in or scheduled to initiate individual psychotherapy to avoid treatment interference
- Psychotropic medication permitted if dose was stable over the past 2 weeks
See the full eligibility criteria
- Age 60 or older
- Ability to read, write, and speak English
- Located in Las Vegas or surrounding area
- Ability to travel to UNLV campus by self or possible caregiver for regular study visits
- Clinically significant symptoms of depression as evidenced by: 1) Scores \> 5 on the Geriatric Depression Scale-Short Form (GDS-SF)
- Mild cognitive impairment as evidenced by: 1) Scores \> 18 and \< 25 on the Montreal Cognitive Assessment (MoCA)
- Active suicidal ideation
- History of suicide attempt(s)
- Current symptoms of: 1) Psychosis; 2) Active substance use disorder
- Reported history of: 1) Bipolar disorder ("manic depression"); 2) Intellectual disability
- Currently in or scheduled to initiate individual psychotherapy to avoid treatment interference
- Psychotropic medication permitted if dose was stable over the past 2 weeks
- Currently living in an institutional setting (e.g., assisted living, inpatient, skilled nursing)
- Presence of notable memory-specific cognitive deficits as evidenced by: scores \< 9 on the MoCA memory subscale (rendering it difficult to participate in and track/recall events for weekly psychotherapy)
The study team makes the final eligibility decision.
Where it's taking place
- Las Vegas, Nevada, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Las Vegas, Nevada, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.